Interestingly the N-terminal peptide of ANXA1, Ac2-26 was able to stimulate direct migration of WS1 cells in high glucose treatment possibly due to the increased receptor expression observed in hyperglycemia conditions. Here, ANXA1 is linked to Hyperglycemia.